Effect of naringin on ammonium chloride-induced hyperammonemic rats: A dose-dependent study  by Arumugam, Ramakrishnan et al.
Available online at www.sciencedirect.comScienceDirect
Journal of Acute Medicine 6 (2016) 55e60
www.e-jacme.comOriginal Research
Effect of naringin on ammonium chloride-induced hyperammonemic rats:
A dose-dependent study
Ramakrishnan Arumugam, Vijayakumar Natesan*, Renuka Mani
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalai Nagar, India
Received 23 November 2015; revised 27 July 2016; accepted 16 August 2016
Available online 22 September 2016AbstractIntroduction: In mammals, ammonia is primarily a toxin that affects the central nervous system, leading to liver damage and urea cycle disorder.
Increased accumulation of ammonia results in a spectrum of effects on the central nervous system exerted through both excitatory and inhibitory
neurotransmission. The aim of this investigation was to examine the protective effect of naringin on ammonium chloride (NH4Cl)-induced
hyperammonemic rats.
Materials and methods: Male albino Wistar rats were induced with intraperitoneal injections of NH4Cl [100 mg/kg body weight (b.w.)] and were
treated with different concentrations of naringin (40 mg/kg, 80 mg/kg, and 160 mg/kg of b.w.) 3 times/wk for 8 consecutive weeks.
Results: Hyperammonemic rats showed elevated levels of ammonia, uric acid, creatinine, and bilirubin, and a reduced level of plasma urea. Body
weights of normal and experimental rats were also measured. Oral administration of naringin significantly decreased the levels of blood
ammonia, uric acid, creatinine, and bilirubin, and drastically increased the level of plasma urea.
Conclusion: Among the three doses, 80 mg/kg b.w. of naringin exhibited a more efficient antihyperammonemic effect in NH4Cl-induced
hyperammonemic rats. Therefore, this study proves the protective effect of naringin in NH4Cl-induced hyperammonemic rats in an apparent
dose-dependent manner.
Copyright © 2016, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Ammonia is a neurotoxin that is implicated in the patho-
genesis of several metabolic encephalopathies. Ammonia con-
centration is increased as a result of hepatic dysfunction or
encephalopathy through a variety of impaired mechanisms. In
hyperammonemic conditions, ammonia diffuses from the blood
into the brain and produces neurotoxic effects.1 Antiepileptic
drugs such as valproate and salicylate cause hyperammonemia
in mammalian systems.2,3 The most severe effects of high
ammonia levels occur in the brain characterized by personality
and behavior changes, confusion, and tremors, which may even* Corresponding author. Department of Biochemistry and Biotechnology,
Faculty of Science, Annamalai University, Annamalai Nagar 608 002, India.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).lead to coma and death.4,5 Screening and appraisal of drugs,
essentially from traditional medicinal plants and natural prod-
ucts, for their antihyperammonemic activity are currently being
pursued. This can be achieved by focusing research on active
principles (phytochemicals). Activities of flavonoids are related
to their chemical structures, mainly the position and degree of
the hydroxyl group, which is important to exert their biological
and pharmacological properties.6,7
Flavonoids are naturally occurring polyphenolic com-
pounds that are thought to have positive effects on human
health.8 Naringin (40,5,7-trihydroxy flavonone 7-
rhamnoglucoside; Figure 1) is one of the flavonoid com-
pounds9 which is abundantly found in grapefruit and citrus-
related species.10,11 In recent years, a great deal of attention
has been focused on the role of flavonoids in the prevention of
chronic diseases.12 Several studies have reported that naringiny Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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betic,14 renoprotective,15 cardioprotective,16 anticancer,17
antimutagenic,18 and anti-inflammatory effects.19 Further-
more, it was found that naringin was able to traverse the
bloodebrain barrier.20 Naringin has empirically been proved
to have no side effects, as humans have been ingesting grapes
and citrus fruits for a long time.21
Accordingly, this study was designed to determine the
possible protective effect of naringin on the levels of blood
ammonia, plasma urea, uric acid, serum creatinine, and bili-
rubin and on body weight changes in ammonium chloride
(NH4Cl)-induced hyperammonemia in albino Wistar rats.
2. Materials and methods2.1. Experimental animalsThis study was carried out in male albino Wistar rats
(180e200 g) obtained from the Central Animal House, Rajah
Muthiah Medical College and Hospital (Reg. No. 160/1999/
CPCSEA; Approval No. 1076, 17.04.2014), Annamalai Uni-
versity, Tamil Nadu, India. The rats were housed in poly-
propylene cages (47 cm  34 cm  20 cm) lined with husk,
renewed every 24 hours under a 12:12-hour light/dark cycle at
23 ± 2C, and had free access to tap water and food. The rats
were fed on a standard pellet diet (Pranav Agro Industries
Ltd., Hyderabad, India). The experiment was carried out ac-
cording to the guidelines of the Committee for the Purpose of
Control and Supervision of Experiments on Animals
(CPCSEA), New Delhi, India, and was approved by the Ani-
mal Ethical Committee of Annamalai University, in accor-
dance with the guidelines of National Institute of Nutrition,
Hyderabad, India.2.2. ChemicalsNaringin was purchased from Sigma Chemical Company
(St Louis, MO, USA). NH4Cl and other chemicals used in this
study were of analytical grade and obtained from E. Merck-
Bangalore and HIMEDIA-Mumbai (India).Figure 1. Structure of naringin.2.3. Experimental induction of hyperammonemiaHyperammonemia was induced in Wistar rats by intraper-
itoneal injections of a freshly prepared solution of NH4Cl at a
dose of 100 mg/kg body weight (b.w.) 3 times/wk for 8
consecutive weeks.22,232.4. Experimental designThe animals were randomized and divided into six groups
of six animals each, as shown in the following:
Group 1: normal rats
Group 2: rats orally administered with naringin (160 mg/kg
b.w.)
Group 3: rats treated with NH4Cl (100 mg/kg b.w.)
intraperitoneally
Group 4: rats treated with NH4Cl þ naringin (40 mg/kg
b.w.)
Group 5: rats treated with NH4Cl þ naringin (80 mg/kg
b.w.)
Group 6: rats treated with NH4Cl þ naringin (160 mg/kg
b.w.)
At the end of the experimental period (8th week), all rats
were fasted overnight and sacrificed by cervical dislocation.
Blood samples were collected for the estimation of blood
ammonia, plasma urea, uric acid, serum creatinine, and
bilirubin.2.5. Measurement of body weightDuring the experimental period, body weights of experi-
mental rats were measured every week using a digital
balance.242.6. Biochemical estimations
2.6.1. Determination of blood ammonia
To determine the levels of ammonia in the blood,25 trie-
thanolamine (151mM, 200 mL) buffered substrate (a-keto-
glutarate) was added to the blood (20 mL), mixed thoroughly,
and the absorbance was measured at 480 nm.
2.6.2. Estimation of plasma urea
The level of plasma urea was estimated26 by adding 0.2 mL
of plasma, and 3.5 mL of double-distilled water was added to
then. Then 0.35M sulfuric acid (0.4 mL) and 10% sodium
tungstate (0.3 mL) were added and centrifuged. To the su-
pernatant (2.1 mL), diacetyl monoxime (0.5 mL), water
(2 mL), and sulfuric acidephosphoric acid mixture (1.6 mL)
were added, the mixture was boiled for 30 minutes and cooled,
and the absorbance was read at 480 nm.
2.6.3. Estimation of plasma uric acid
Plasma uric acid was determined by adding tungstic acid
(5.4 mL) to plasma (0.6 mL). The contents were centrifuged.
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1% phosphotungstic acid reagent (0.6 mL) were added, the
mixture was incubated at 25C for 10 minutes, and the
absorbance was read at 700 nm.27
2.6.4. Estimation of serum creatinine
Serum creatinine was determined by adding alkaline picrate
(2 mL) to 3 mL of deproteinized supernatant (prepared by
centrifugation of 0.2 mL of serum with 4.3 mL of 10%
tricarboxylic acid cycle). The mixture was kept at 25C for 30
minutes and the absorbance was read at 520 nm.28
2.6.5. Estimation of serum bilirubin
The level of bilirubin in serum was determined by adding
absolute methanol (2.5 mL) 1.5% hydrochloric acid (0.5 mL),
and a diazo reagent (0.5 mL) to serum (0.2 mL), which were
mixed thoroughly and kept at room temperature for 30 mi-
nutes, and the absorbance was measured at 540 nm.292.7. Statistical analysisThe statistical significance was expressed by one-way
analysis of variance using the Software Package for the So-
cial Science (SPSS) Version 15, followed by Duncan’s mul-
tiple range test. Each group contained six animals and the
results were expressed as mean ± standard deviation. A p
value <0.05 was considered statistically significant.30
3. Results
Figure 2 shows a significant decrease in the final body
weight of NH4Cl-treated rats as compared with normal rats.
No significant change was observed in rats treated with nar-
ingin alone compared with rats. Naringin-treated hyper-
ammonemic rats showed nearly normalized body weights as
compared with hyperammonemic rats.Figure 2. Effect of naringin on changes in the body weight of experimental
rats. Numbers in the figure represents the groups of experimental rats: 1,
normal rats; 2, rats treated with naringin (160 mg/kg b.w.); 3, rats treated with
NH4Cl (100 mg/kg b.w.); 4, rats treated with NH4Cl þ naringin (40 mg/kg
b.w.); 5, rats treated with NH4Cl þ naringin (80 mg/kg b.w.); and 6, rats
treated with NH4Cl þ naringin (160 mg/kg b.w.). b.w. ¼ body weight;
NH4Cl ¼ ammonium chloride.NH4Cl-induced hyperammonemic rats showed a significant
increase in the levels of blood ammonia and plasma uric acid,
and a decrease in the level of plasma urea compared with the
normal rats. Oral administration of naringin (40 mg/kg, 80 mg/
kg, and 160 mg/kg b.w.) for a period of 8 consecutive weeks to
hyperammonemic rats was found to significantly decrease the
levels of blood ammonia and plasma uric acid, and increase
the level of plasma urea. Among the three doses, the
maximum lowering effect of naringin was observed at the dose
of 80 mg/kg b.w. (Figures 3e5).
Figures 6 and 7 demonstrate the levels of serum creatinine
and bilirubin in experimental rats. A significant increase in the
levels of serum creatinine and bilirubin was observed in
hyperammonemic rats. Oral administration of naringin to
hyperammonemic rats had significant changes in these levels
to near normal. Naringin showed a highly significant effect at
a dose of 80 mg/kg b.w. compared with the effects at doses of
40 mg/kg and 160 mg/kg b.w. Based on these data, the
effective dose was fixed at 80 mg/kg b.w. Hence, further
studies were carried out using this effective dose.
4. Discussion
Ammonia is a key factor in the pathogenesis of hepatic
encephalopathy, a major complication in acute and chronic
liver failure and other hyperammonemic states, such as inborn
errors of urea synthesis, during hepatic inadequacy, large
quantities of ammonia in portal blood escapes, from the
detoxification process and enters systemic circulation. Thus,
blood and tissue (brain) ammonia levels are elevated rapidly.31
Ammonia is a potent inhibitor of a-ketoglutarate dehydroge-
nase, the rate limiting enzyme in tricarboxylic acid cycle
causing the accumulation of a-ketoglutarate, which stimulates
glutamate formation in both astrocytes and neurons.32 Previ-
ous studies33 have reported that hyperammonemic rats showed
an increased body weight due to the accumulation of lipid
metabolites, proteins, and amino acids in tissues and blood
circulation. In our study, naringin-treated hyperammonemic
rats showed near normalized body mass as compared withFigure 3. Effect of naringin on changes in the level of blood ammonia of
experimental rats. Numbers in the figure represents the groups of experimental
rats: 1, normal rats; 2, rats treated with naringin (160 mg/kg b.w.); 3, rats
treated with NH4Cl (100 mg/kg b.w.); 4, rats treated with NH4Cl þ naringin
(40 mg/kg b.w.); 5, rats treated with NH4Cl þ naringin (80 mg/kg b.w.); and 6,
rats treated with NH4Cl þ naringin (160 mg/kg b.w.). b.w. ¼ body weight;
NH4Cl ¼ ammonium chloride.
Figure 4. Effect of naringin on changes in the level of plasma urea of
experimental rats. Numbers in the figure represents the groups of experimental
rats: 1, normal rats; 2, rats treated with naringin (160 mg/kg b.w.); 3, rats
treated with NH4Cl (100 mg/kg b.w.); 4, rats treated with NH4Cl þ naringin
(40 mg/kg b.w.); 5, rats treated with NH4Cl þ naringin (80 mg/kg b.w.); and 6,
rats treated with NH4Cl þ naringin (160 mg/kg b.w.). b.w. ¼ body weight;
NH4Cl ¼ ammonium chloride.
Figure 5. Effect of naringin on changes in the level of plasma uric acid of
experimental rats. Numbers in the figure represents the groups of experimental
rats: 1, normal rats; 2, rats treated with naringin (160 mg/kg b.w.); 3, rats
treated with NH4Cl (100 mg/kg b.w.); 4, rats treated with NH4Cl þ naringin
(40 mg/kg b.w.); 5, rats treated with NH4Cl þ naringin (80 mg/kg b.w.); and 6,
rats treated with NH4Cl þ naringin (160 mg/kg b.w.). b.w. ¼ body weight;
NH4Cl ¼ ammonium chloride.
Figure 6. Effect of naringin on changes in the level of serum creatinine of
experimental rats. Numbers in the figure represents the groups of experimental
rats: 1, normal rats; 2, rats treated with naringin (160 mg/kg b.w.); 3, rats
treated with NH4Cl (100 mg/kg b.w.); 4, rats treated with NH4Cl þ naringin
(40 mg/kg b.w.); 5, rats treated with NH4Cl þ naringin (80 mg/kg b.w.); and 6,
rats treated with NH4Cl þ naringin (160 mg/kg b.w.). b.w. ¼ body weight;
NH4Cl ¼ ammonium chloride.
Figure 7. Effect of naringin on changes in the level of serum bilirubin of
experimental rats. Numbers in the figure represents the groups of experimental
rats: 1, normal rats; 2, rats treated with naringin (160 mg/kg b.w.); 3, rats
treated with NH4Cl (100 mg/kg b.w.); 4, rats treated with NH4Cl þ naringin
(40 mg/kg b.w.); 5, rats treated with NH4Cl þ naringin (80 mg/kg b.w.); and 6,
rats treated with NH4Cl þ naringin (160 mg/kg b.w.). b.w. ¼ body weight;
NH4Cl ¼ ammonium chloride.
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plementation (at a dose of 80 mg/kg b.w.) to hyperammonemic
rats has managed to have an affirmative effect in opposition to
hyperlipidemia.The liver contains all the detoxification enzymes that are
needed for the urea cycle, which helps in the excretion of
excess ammonia.34 The increased blood ammonia and
decreased urea indicate the hyperammonemic condition in
NH4Cl-treated rats.
35 This may be due to the liver damage
caused by the urea cycle disorder and ammonia intoxication.36
Naringin-administered hyperammonemic rats showed a
significantly decreased level of circulatory ammonia and an
increase in urea biosynthesis when compared with corre-
sponding NH4Cl-treated rats. Various investigations have
documented that phytochemicals containing flavonoids offer
ammonia detoxification by removing excess ammonia, uric
acid, and creatinine during various disease conditions such as
hyperammonemia, nephrotoxicity, etc.37 The reduction in
ammonia and enhancement in urea synthesis showed anti-
hyperammonemic effects of naringin, favoring normalization
of urea cycle defects and reduction of hyperammonemic
complications. These observations clearly indicate that nar-
ingin could exert a potent antihyperammonemic effect.
Administration of NH4Cl to rats exhibited a significant
increase in plasma uric acid and serum creatinine, and a
decrease in plasma urea concentration when compared with
the control group. Blood urea nitrogen, uric acid, and creati-
nine levels are useful indicators of renal function. Renal
damage can be accompanied by an increase in blood urea
nitrogen, uric acid, and creatinine, indicating reduced urea,
uric acid, and creatinine clearance.38 In addition to the hepatic
damage, renal damages were also present, as was evident by
the elevation in plasma urea levels, which was considered as a
significant marker of renal dysfunction.39 The earliest
research40 investigated that the levels of plasma uric acid and
serum creatinine were increased, and the level of plasma urea
concentration was decreased after the administration of
NH4Cl. It might be due to dysfunctional and dystrophic
changes in the liver and kidney due to severe renal impair-
ments; as a result, urea excretion decreased and its concen-
tration in plasma increased rapidly. Hyperammonemic rats
treated with naringin showed significantly decreased levels of
plasma uric acid and serum creatinine, and an increase in
plasma urea concentration when compared with NH4Cl-
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naringin.
Serum bilirubin is used as an index for the assessment of
hepatic function, and any abnormal increase in the level of
bilirubin in the serum indicates hepatobiliary diseases and
severe disturbance of the hepatocellular function.41,42 In the
present investigation, the rats induced with NH4Cl showed a
significantly increased level of bilirubin as compared with to
normal rats.
5. Conclusion
Naringin is abundantly present in grapefruit. The juice
composition is very different from that of sweet orange, but
quite similar to that of grapefruit, being rich in naringin (24,
1.96 mg/100 mL). Therefore, approximately 2 L of grape juice
is needed for 40 mg/kg b.w. of naringin that one adult needs to
ingest to achieve a protective effect.43 In the present study,
overall findings suggest that the bioflavonoid naringin has the
potential of an excellent antihyperammonemic agent. The
NH4Cl induced hyperammonemia treated with the naringin in
different concentration (40 mg/kg, 80 mg/kg, and 160 mg/kg
b.w.) in the albino Wistar rats with consequences of alterations
in biochemical parameters components 80 mg/kg b.w. act as
an effective dose of hyperammonemia function.
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